Non-FDG PET in oncology
Clin. transl. oncol. (Print)
; 13(11): 780-786, nov. 2011. tab, ilus
Article
in English
| IBECS
| ID: ibc-125937
Responsible library:
ES1.1
Localization: BNCS
ABSTRACT
Although FDG PET and PET/CT have a well established role in the management of most cancer patients, they also have some limitations. For the last 15-20 years a growing number of non-FDG PET tracers have been used in research. Many of these new PET tracers are being investigated for the non-invasive assessment of different biologic functions in cancer cells. This unique information should contribute to making personalized cancer therapy a reality. This paper reviews the non-FDG PET tracers that are most likely to find clinical application, some of them in the near future (AU)
Search on Google
Collection:
National databases
/
Spain
Database:
IBECS
Main subject:
Tomography, X-Ray Computed
/
Radiopharmaceuticals
/
Fluorodeoxyglucose F18
/
Positron-Emission Tomography
/
Neoplasms
Limits:
Female
/
Humans
/
Male
Language:
English
Journal:
Clin. transl. oncol. (Print)
Year:
2011
Document type:
Article
Institution/Affiliation country:
MD Anderson Cancer Center/Spain
/
Universidad Complutense de Madrid/Spain